Spots Global Cancer Trial Database for Merkel Positron Emission Tomography (PET) Protocol
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Merkel Positron Emission Tomography (PET) Protocol
Official Title: A Phase II Efficacy Study of Chemo-Radiotherapy in PET Stage II and III Merkel Cell Carcinoma of the Skin
Study ID: NCT01013779
Conditions
Study Description
Brief Summary: A Phase II Study designed to evaluate the efficacy of Chemo-Radiotherapy in achieving loco-regional control in patients with Merkel Cell Carcinoma (MCC) of the skin. Patients will undergo PET scans to assist in staging and planning the patient's treatment as well as assessing response at the conclusion of treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Campbelltown, Campbelltown, New South Wales, Australia
Liverpool Hospital, Liverpool, New South Wales, Australia
Royal Prince Alfred, Sydney, New South Wales, Australia
Calvary Mater Newcastle, Waratah, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Radiation Oncology Services - Mater Centre, Brisbane, Queensland, Australia
Princess Alexandra Hospital Radiation Oncology, Brisbane, Queensland, Australia
Royal Brisbane Hospital, Herston, Queensland, Australia
Oncology Research Australia, Toowoomba, Queensland, Australia
Genesis Cancer Care (previously Premion), Tugun, Queensland, Australia
Geelong Hospital, Geelong, Victoria, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Sir Charles Gairdner, Nedlands, Western Australia, Australia
Contact Details
Name: Michael Poulsen
Affiliation: Trans Tasman Radiation Oncology Group
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
